Mikuláš Redecha, Peter Papcun, Marián Križko ml., Martin Gábor, Karol Holomáň, Sylvia Redechová
A uterine myoma is a major cause of morbidity in women in reproductive age. The most likely presentation of myomata
is their impact on the woman’s menstrual cycle or pelvic pressure symptoms. The management of uterine myomata
can be approached medically, surgically, and even with minimal access techniques. The recent introduction of selective
progesterone receptor modulators (SPRMs) and aromatase inhibitors has added more armamentarium to the medical
options of treatment. Uterine artery embolization has now been well-recognized as a uterine-sparing and fertilitypreserving
method for treating myomata. More recently, the introduction of ultrasound waves or radiofrequency
for uterine myoma ablation has been added to the options of minimal access treatment. Our article reviews data on
the non-surgical treatment of uterine myomata.